Robert Leitner is a leader in Global Regulatory Affairs with 25 years of experience in the pharmaceutical industry, currently serving as the Global Regulatory Affairs Therapeutic Area Lead at Biogen since 2024. Previously, they held significant roles at AstraZeneca and Novartis Pharma, demonstrating expertise in developing global regulatory strategies across various therapeutic areas including neuroscience, ophthalmology, and gastroenterology. Robert has a proven track record of successful regulatory approvals and extensive experience working with health authorities such as the EMA and FDA. With a global perspective encompassing regions like Asia, Europe, and North America, they have led project teams and managed regulatory affairs for both small molecules and biologics.
This person is not in any teams
This person is not in any offices